Pacific Crest notes that NXP Semiconductors (NXPI) is trading just 3.2% above the level it was at before its acquisition of Freescale (FSL). The firm continues to be upbeat on the deal. It expects NXP to report in-line results and provide in-line to slightly lower than expected guidance. Pacific Crest thinks the company is facing several near-term headwinds, but it believes that they are largely reflected in the stock. It keeps a $135 price target and Overweight rating on the shares.

Susquehanna analyst Christopher Rolland raised the firm's price target on Impinj (PI) to $150 from $140 and keeps a Positive rating on the shares. The firm said they posted a solid print with additional upside driven by the licensing win from NXP Semiconductors (NXPI). Customer engagements and new RFID markets continue to broaden the opportunity.

BofA raised the firm's price target on Texas Instruments (TXN) to $190 from $175 and keeps a Neutral rating on the shares. TI's small Q1 beat and inline but sequentially rising Q2 sales guidance, "while modest, potentially marks a recovery inflection in industrial chip demand," with positive read-across for U.S. peers such as Analog Devices (ADI), Microchip (MCHP), NXP Semiconductors (NXPI) and On Semiconductor (ON), the analyst tells investors. However, despite an expected recovery, TI's sustained high capex intensity could keep reported calendar year 2024-26 pro-forma EPS below $6 per share, the analyst added.